<DOC>
	<DOCNO>NCT00458328</DOCNO>
	<brief_summary>Z-338 ; PhaseIIb , Single-centre , Randomized , Double-blind , Placebo-controlled , Parallel group study Subjects Functional Dyspepsia , evaluate motility gastro-duodenum ultrasound</brief_summary>
	<brief_title>The Effect Z-338 Subjects With Functional Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<criteria>Postprandial fullness , upper abdominal bloating and/or early satiety least moderate 2 day 7 day Visit 1 . Upper abdominal pain , upper abdominal discomfort , postprandial fullness , upper abdominal bloating , early satiety , nausea , vomit belch least moderate least 2 symptom 2 day 7 day Visit 1 . Subjects heartburn bothersome symptom Subjects present primary complaint relieve stool movement ( IBS ) Subjects diabetes treatment Subjects heartburn moderate</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>